The founder of Jiva Pharma is Dr. Om P. Goel, PhD.
Dr. Goel received Ph.D. in organic chemistry and chemical engineering from Carnegie-Mellon University. Upon the recommendation of Professor Robert B. Carlin, he joined the Parke-Davis’s Research in Detroit. For 35 years at Parke-Davis/Warner-Lambert/Pfizer, Dr. Goel contributed to the development of over 150 compounds tested in the clinic, including anti-infectives, anti-cancer compounds, ACE inhibitors, and cognition enhancing drugs. Drugs, which he helped develop, and used around the world are Accupril®, Lipitor® and Lopid®.
Post retirement, after 2 years as a VP at a CRO, Dr. Goel founded SSV Therapeutics in 2004, and Jiva Pharma in 2007 after being awarded a 2007 loan of $250,000 from the State of Michigan for the development of JIVA-001 (JP-1), for treating early stages of Alzheimer’s disease. A U.S Patent 7,893, 289 was issued for this invention.